Everything you need to know about Daratumumab and Multiple Myeloma
FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received at least three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to other therapies. Our myeloma panel is talking to the father of daratumumab, Dr. Torben Plesner, on the use of this drug in treating multiple myeloma.
Register at: http://www.curetalks.com/event/rsvp/Everything-you-need-to-know-about-Daratumumab-and-Multiple-Myeloma/248/?upcoming=yes
Register at: http://www.curetalks.com/event/rsvp/Everything-you-need-to-know-about-Daratumumab-and-Multiple-Myeloma/248/?upcoming=yes
All things considered, nothing I can say except for incredible! I trust you'll make more helpful articles in the up and coming days.
ReplyDeleteTenmou, the Angel Investment Group in Bahrain Case Solution
Pleasant line use and great picture this post. this post will be successfully a debt of gratitude is in order for sharing.
ReplyDeleteOnline Programming Homework Help